Pleural Effusion: A Rare Side Effect of Nilotinib—A Case Report
Joint Authors
Gündüz, Eren
Karagülle, Mustafa
Andıç, Neslihan
Akay, Olga Meltem
Üsküdar Teke, Hava
Şahin, Deniz Gören
Source
Issue
Vol. 2014, Issue 2014 (31 Dec. 2014), pp.1-3, 3 p.
Publisher
Hindawi Publishing Corporation
Publication Date
2014-09-09
Country of Publication
Egypt
No. of Pages
3
Main Subjects
Abstract EN
Pleural effusion, as a side effect of tyrosine kinases, may be seen as most commonly associated with dasatinib and very rarely seen with nilotinib.
In this report we present a chronic phase of CML case that was treated with nilotinib due to imatinib (Gleevec) allergy and had pleural effusion with nilotinib at 5th year of treatment.
If pleural effusion develops in patients taking nilotinib and if this effusion is exudative and lymphocyte predominant, after ruling out pulmonary and cardiac etiologies, it must be associated with nilotinib; according to stage of effusion drug should be discontinued and/or steroid should be started and/or surgery should be performed.
American Psychological Association (APA)
Üsküdar Teke, Hava& Akay, Olga Meltem& Şahin, Deniz Gören& Karagülle, Mustafa& Gündüz, Eren& Andıç, Neslihan. 2014. Pleural Effusion: A Rare Side Effect of Nilotinib—A Case Report. Case Reports in Medicine،Vol. 2014, no. 2014, pp.1-3.
https://search.emarefa.net/detail/BIM-1034767
Modern Language Association (MLA)
Üsküdar Teke, Hava…[et al.]. Pleural Effusion: A Rare Side Effect of Nilotinib—A Case Report. Case Reports in Medicine No. 2014 (2014), pp.1-3.
https://search.emarefa.net/detail/BIM-1034767
American Medical Association (AMA)
Üsküdar Teke, Hava& Akay, Olga Meltem& Şahin, Deniz Gören& Karagülle, Mustafa& Gündüz, Eren& Andıç, Neslihan. Pleural Effusion: A Rare Side Effect of Nilotinib—A Case Report. Case Reports in Medicine. 2014. Vol. 2014, no. 2014, pp.1-3.
https://search.emarefa.net/detail/BIM-1034767
Data Type
Journal Articles
Language
English
Notes
Includes bibliographical references
Record ID
BIM-1034767